Shaolin Capital Management’s Tevogen Bio Holdings TVGN Stock Holding History

Shaolin Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,259	Closed	-$9.43M	–	709
2022 Q4	$9.43M	Sell	18,259 -4,247	-19%	-$2.17M	0.28%	98
2022 Q3	$11.4M	Buy	22,506 +13,269	+144%	+$6.69M	0.31%	71
2022 Q2	$4.62M	Buy	+9,237	New	+$4.62M	0.11%	252

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Shaolin Capital Management's TVGN Position: Q1 2023 in Review

Shaolin Capital Management sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 18,259 shares — an estimated $9.43M sold.

Shaolin Capital Management first reported a position in TVGN in Q2 2022 and held it in 3 quarters. The position peaked at $11.4M in Q3 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Shaolin Capital Management reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
Shaolin Capital Management sold 18,259 Tevogen Bio Holdings shares in Q1 2023, an estimated $9.43M.
Shaolin Capital Management first reported a position in Tevogen Bio Holdings in Q2 2022 and held it in 3 quarters.
Shaolin Capital Management's Tevogen Bio Holdings position peaked at $11.4M in Q3 2022.
4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Shaolin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.